Cian Healthcare Ltd. Receives Trading Approval for 2.5 Crore Equity Shares
Mumbai, March 31, 2026 – Cian Healthcare Ltd. announced today that it has received trading approval from the Bombay Stock Exchange (BSE) for 2,50,00,000 (Two Crores Fifty Lakhs) fully paid-up equity shares with a face value of INR 10/- (Indian Rupees Ten Only) each. The approval, received on March 30, 2026, follows a resolution plan approved by the National Company Law Tribunal (NCLT) on December 18, 2025.The approved shares are divided into two categories: 12,50,000 (Twelve Lakhs Fifty Thousand) shares were approved for public shareholders, and 2,37,50,000 (Two Crores Thirty-Seven Lakhs Fifty Thousand) shares for promoters. The trading of these shares is scheduled to commence on April 2, 2026.
The approval facilitates the admission of these equity shares for trading on the BSE Limited. Cian Healthcare Ltd. continues to keep stakeholders and regulatory authorities informed of developments regarding this matter.
Table: Details of Trading Approval
| Particulars | Description |
|---|---|
| Regulatory Authority | BSE Limited |
| Approval Details | Trading Approval for 2,50,00,000 fully paid-up equity shares with a face value of INR 10/- each, allotted to public shareholders and promoters. |
| Impact on Listed Entity | The approval enables trading of the equity shares on the BSE Limited. |
| Validity Period | Not Applicable |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.